The traditional healthcare system offered a reactive model: when you fall ill, you visit a…
TechPharus
Latest Posts
Blueprint for Tomorrow: Abu Dhabi’s Genomic Vision for Healthcare
Abu Dhabi is leading a genomic revolution that promises to reshape healthcare by deeply understanding…
The UAE’s Expanding Life Sciences Ecosystem: A New Global Powerhouse
The UAE’s healthcare and life-science sector is experiencing rapid growth, powered by a robust ecosystem…
Building the Future of Pharma: Abu Dhabi’s Strategic Leap
Abu Dhabi’s Pharmaceutical Sector: Rising to Global Prominence Over the past decade, Abu Dhabi—one of…
How the UAE is Shaping the Future of Longevity and Healthspan
The United Arab Emirates is swiftly positioning itself as a global leader in the Longevity…
Interview with Dr. Priyanka Mathur, MediPocket World
We recently spoke to Dr. Priyanka Mathur, a visionary healthcare leader with international healthcare experience…
HealthTech News
- Global physical activity remains low despite two decades of guideline updateson March 9, 2026 at 9:40 pm
The prevalence of physical activity among the global population has remained low for the last two decades despite a majority of countries making notable progress in developing policies that include physical activity, UTHealth Houston researchers have found. The study is published in Nature Health and was led by principal investigator Andrea Ramírez Varela, MD, Ph.D., MPH, assistant professor in the Department of Epidemiology at UTHealth Houston School of Public Health.
- The tryptophan switch? Why exercise boosts your moodon March 9, 2026 at 9:20 pm
One in five Canadians is living with mental health challenges such as anxiety and depression at any one time.
- Blood immune ‘fingerprint’ may help predict serious side effects of new Alzheimer’s drugon March 9, 2026 at 9:20 pm
A team of University of Kentucky researchers has uncovered a surprising clue in the battle against Alzheimer’s disease that could help doctors predict, and ultimately prevent, a common side effect of the newest generation of Alzheimer’s therapies. Their findings, recently published in Nature Communications, reveal a distinct immune “fingerprint” in the blood of patients who develop amyloid-related imaging abnormalities (ARIA) after treatment with lecanemab—the first Food and Drug Administration-approved drug shown to slow Alzheimer’s disease progression.
- New research brings hope for earlier detection of pre-eclampsiaon March 9, 2026 at 9:00 pm
Pre-eclampsia is a life-threatening pregnancy complication that can strike suddenly, endangering both mother and child. Despite affecting roughly one in twenty pregnancies worldwide, clinicians have long lacked a reliable method to predict its onset. Now, a study published in Genome Biology may change that. Led by Dr. Manvendra Singh (INEM, and Institut Imagine) alongside collaborators from the Max Delbrück Center, Cornell University and the University of Bath, researchers have uncovered “hidden” biological signals that could serve as an early-warning system.
- Researcher disputes claim that multilingualism promotes better brain agingon March 9, 2026 at 8:40 pm
University of Houston professor of psychology Arturo Hernandez is disputing a high-profile study published in the journal Nature Aging claiming that people who live in multilingual countries show healthier brain aging. Though the study got lots of attention, Hernandez reports in the journal Brain and Language that the findings warrant cautious interpretation and reframing of public health implications.




